Sophie De Boer
About Sophie De Boer
Sophie De Boer is a co-founder of Generate Biomedicines, Inc. and Laronde, with a strong academic background in Cancer Genomics and Developmental Biology. She has held various positions in notable companies, including Flagship Pioneering and Biogen, and has extensive experience in research and strategy development.
Work at Generate Biomedicines
Sophie De Boer serves as a Co-Founder at Generate Biomedicines, Inc. since 2018. The company is located in Cambridge, Massachusetts, and focuses on developing innovative biomedicines using a unique platform. Her role involves strategic decision-making and guiding the company's vision in the biopharmaceutical sector.
Education and Expertise
Sophie De Boer holds a Master of Science (MS) in Cancer Genomics and Developmental Biology from Utrecht University, completed between 2007 and 2009. She also earned a Doctor of Philosophy (PhD) in Cell Biology and Anatomy from Leiden University, where she studied from 2009 to 2015. Her educational background provides a strong foundation in biomedical sciences and research methodologies.
Background in Flagship Pioneering
Sophie De Boer has a significant history with Flagship Pioneering, where she has held multiple roles. She worked as a Senior Associate from 2019 to 2021, then transitioned to Principal from 2021 to 2024. In 2024, she took on the role of Senior Principal. Her experiences at Flagship Pioneering have contributed to her expertise in venture creation and biotechnology.
Previous Roles and Experience
Prior to her current positions, Sophie De Boer gained diverse experience in the biotechnology field. She worked as a Consultant in Corporate Development & Strategy at Biogen from 2016 to 2017. Additionally, she interned at PureTech Health from 2014 to 2017 and held various roles at Harvard University, including PhD Graduate Student and Postdoctoral Fellow from 2009 to 2017.
Involvement in Laronde
Sophie De Boer is a Co-Founder of Laronde, a company she has been part of since 2017. Based in Cambridge, Massachusetts, Laronde focuses on developing RNA-based therapeutics. Her involvement in both Generate Biomedicines and Laronde highlights her commitment to advancing biomedicine through innovative approaches.